keyword
https://read.qxmd.com/read/38634580/-morphological-predictors-of-water-electrolyte-disorders-in-patients-with-preventive-ileostomy-after-rectal-resection-for-cancer
#1
JOURNAL ARTICLE
A I Maksimkin, Z A Bagatelia, V M Kulushev, E N Gordienko, M S Lebedko, S S Anikina, E P Shin
OBJECTIVE: To analyze morphological changes in wall of functioning and non-functioning small intestine in patients with preventive ileostomy and to determine histological predictors of water-electrolyte disorders. MATERIAL AND METHODS: We prospectively analyzed 57 patients >18 years old who underwent rectal resection with preventive ileostomy between January 2022 and November 2023. Anthropometric data included gender, age, body mass index, ECOG and ASA classes...
2024: Khirurgiia
https://read.qxmd.com/read/38630291/comparative-performance-of-scfv-based-anti-bcma-car-formats-for-improved-t-cell-therapy-in-multiple-myeloma
#2
JOURNAL ARTICLE
Sophia Stock, Luisa Fertig, Adrian Gottschlich, Janina Dörr, Florian Märkl, Lina Majed, Vivien D Menkhoff, Ruth Grünmeier, Kai Rejeski, David M Cordas Dos Santos, Sebastian Theurich, Michael von Bergwelt-Baildon, Stefan Endres, Marion Subklewe, Sebastian Kobold
In multiple myeloma (MM), B cell maturation antigen (BCMA)-directed CAR T cells have emerged as a novel therapy with potential for long-term disease control. Anti-BCMA CAR T cells with a CD8-based transmembrane (TM) and CD137 (41BB) as intracellular costimulatory domain are in routine clinical use. As the CAR construct architecture can differentially impact performance and efficacy, the optimal construction of a BCMA-targeting CAR remains to be elucidated. Here, we hypothesized that varying the constituents of the CAR structure known to impact performance could shed light on how to improve established anti-BCMA CAR constructs...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630101/size-dependent-blue-emission-from-europium-doped-strontium-fluoride-nanoscintillators-for-x-ray-activated-photodynamic-therapy
#3
JOURNAL ARTICLE
Natasha Policei Marques, Mileni M Isikawa, Zeinaf Muradova, Toby Morris, Ross Berbeco, Eder J Guidelli
Successful implementation of X-ray-activated photodynamic therapy (X-PDT) is challenging because most photosensitizers (PSs) absorb light in the blue region, but few nanoscintillators produce efficient blue scintillation. Here, we developed efficient blue-emitting SrF2 :Eu scintillating nanoparticles. Our optimized synthesis conditions resulted in cubic nanoparticles with <mml:math xmlns:mml="https://www.w3.org/1998/Math/MathML"><mml:semantics><mml:mo>∼</mml:mo> <mml:annotation>$\sim $</mml:annotation></mml:semantics> </mml:math> 32 nm diameter and blue emission at 416 nm...
April 17, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38625651/the-contradictory-role-of-febuxostat-in-abcg2-expression-and-potentiating-hypericin-mediated-photodynamic-therapy-in-colorectal-cancers
#4
JOURNAL ARTICLE
Aaron King, Thomas Maisey, Erica L Harris, James A Poulter, David G Jayne, M Ibrahim Khot
Photodynamic Therapy (PDT) is an emerging method to treat colorectal cancers (CRC). Hypericin (HYP) is an effective mediator of PDT and the ABCG2 inhibitor, Febuxostat (FBX) could augment PDT. HT29 and HEK293 cells showed light dependant cytotoxic response to PDT in both 2D and 3D cell models. FBX co-treatment was not found to improve PDT cytotoxicity. Next, ABCG2 protein expression was observed in HT29 but not in HEK293 cells. However, ABCG2 gene expression analysis did not support protein expression results as ABCG2 gene expression results were found to be higher in HEK293 cells...
April 16, 2024: Photochemical & Photobiological Sciences
https://read.qxmd.com/read/38623968/ezh2-suppresses-ferroptosis-in-hepatocellular-carcinoma-and-reduces-sorafenib-sensitivity-through-epigenetic-regulation-of-tfr2
#5
JOURNAL ARTICLE
Yongwei Lai, Xu Han, Bo Xie, Yan Xu, Zhengyi Yang, Didi Wang, Wei Li, Yaohong Xie, Wenqi Song, Xiaohong Zhang, Jia Qi Xia, Pengxia Zhang
Enhancing sensitivity to sorafenib can significantly extend the duration of resistance to it, offering substantial benefits for treating patients with hepatocellular carcinoma (HCC). However, the role of ferroptosis in influencing sorafenib sensitivity within HCC remains pivotal. The enhancer of zeste homolog 2 (EZH2) plays a significant role in promoting malignant progression in HCC, yet the relationship between ferroptosis, sorafenib sensitivity, and EZH2 is not entirely clear. Bioinformatic analysis indicates elevated EZH2 expression in HCC, predicting an unfavorable prognosis...
April 16, 2024: Cancer Science
https://read.qxmd.com/read/38621615/deciphering-the-monocyte-targeting-mechanisms-of-pegylated-cationic-liposomes-by-investigating-the-biomolecular-corona
#6
JOURNAL ARTICLE
Rasmus Münter, Martin Bak, Mikkel E Thomsen, Ladan Parhamifar, Allan Stensballe, Jens B Simonsen, Kasper Kristensen, Thomas L Andresen
Cationic liposomes specifically target monocytes in blood, rendering them promising drug-delivery tools for cancer immunotherapy, vaccines, and therapies for monocytic leukaemia. The mechanism behind this monocyte targeting ability is, however, not understood, but may involve plasma proteins adsorbed on the liposomal surfaces. To shed light on this, we investigated the biomolecular corona of three different types of PEGylated cationic liposomes, finding all of them to adsorb hyaluronan-associated proteins and proteoglycans upon incubation in human blood plasma...
April 13, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38618976/immunotherapy-and-the-ovarian-cancer-microenvironment-exploring-potential-strategies-for-enhanced-treatment-efficacy
#7
REVIEW
Zhi-Bin Wang, Xiu Zhang, Chao Fang, Xiao-Ting Liu, Qian-Jin Liao, Nayiyuan Wu, Jing Wang
Despite progress in cancer immunotherapy, ovarian cancer (OC) prognosis continues to be disappointing. Recent studies have shed light on how not just tumour cells, but also the complex tumour microenvironment, contribute to this unfavourable outcome of OC immunotherapy. The complexities of the immune microenvironment categorize OC as a 'cold tumour'. Nonetheless, understanding the precise mechanisms through which the microenvironment influences the effectiveness of OC immunotherapy remains an ongoing scientific endeavour...
April 15, 2024: Immunology
https://read.qxmd.com/read/38612893/metformin-a-dual-role-player-in-cancer-treatment-and-prevention
#8
REVIEW
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, Huda Dahman, Samhar Alouch, Ahmad Aljada
Cancer continues to pose a significant global health challenge, as evidenced by the increasing incidence rates and high mortality rates, despite the advancements made in chemotherapy. The emergence of chemoresistance further complicates the effectiveness of treatment. However, there is growing interest in the potential of metformin, a commonly prescribed drug for type 2 diabetes mellitus (T2DM), as an adjuvant chemotherapy agent in cancer treatment. Although the precise mechanism of action of metformin in cancer therapy is not fully understood, it has been found to have pleiotropic effects, including the modulation of metabolic pathways, reduction in inflammation, and the regulation of cellular proliferation...
April 6, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612619/shedding-light-on-chemoresistance-the-perspective-of-photodynamic-therapy-in-cancer-management
#9
REVIEW
Fernanda Viana Cabral, Jose Quilez Alburquerque, Harrison James Roberts, Tayyaba Hasan
The persistent failure of standard chemotherapy underscores the urgent need for innovative and targeted approaches in cancer treatment. Photodynamic therapy (PDT) has emerged as a promising photochemistry-based approach to address chemoresistance in cancer regimens. PDT not only induces cell death but also primes surviving cells, enhancing their susceptibility to subsequent therapies. This review explores the principles of PDT and discusses the concept of photodynamic priming (PDP), which augments the effectiveness of treatments like chemotherapy...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610950/modulation-of-shla-g-pd-1-and-pd-l1-expression-in-cervical-lesions-following-imiquimod-treatment-and-its-association-with-treatment-success
#10
JOURNAL ARTICLE
Andrej Cokan, Neila Caroline Henrique da Silva, Rajko Kavalar, Igor But, Maja Pakiž, Sheilla Andrade de Oliveira, Fabiana Oliveira Dos Santos Gomes, Rodrigo Soares da Silva, Christina Alves Peixoto, Norma Lucena-Silva
(1) Background: Cervical intraepithelial neoplasia (CIN) is a precancerous condition linked to human papillomavirus (HPV) infection, often necessitating surgical interventions carrying the risk of subsequent preterm births. This study explores the potential of imiquimod (IMQ), as a non-invasive alternative treatment. The focus is on understanding IMQ impact on immune checkpoint molecules, particularly PD-1, PD-L1, and sHLA-G, which play pivotal roles in shaping immune responses and cancer progression. (2) Methods: Forty-three patients diagnosed with a high-risk squamous intraepithelial lesion (HSIL, p16-positive) self-applied 5% IMQ encapsulated in sachets containing 250 g of cream into the vaginal cavity three times a week for 16 weeks...
March 25, 2024: Cancers
https://read.qxmd.com/read/38610054/the-effect-of-physical-therapy-and-mechanical-stimulation-on-dysfunction-of-lower-extremities-after-total-pelvic-exenteration-in-cervical-carcinoma-patient-with-rectovesicovaginal-fistula-induced-by-radiotherapy-a-case-report
#11
JOURNAL ARTICLE
Wujian Lin, Bing Yao, Jiahui He, Shuangyan Lin, Yafei Wang, Fangting Chen, Weichao Zhang, Jiashu Yang, Zhihong Ye, Jianguang Qiu, Yuling Wang
BACKGROUND: Total pelvic exenteration is the ultimate solution for rectovesicovaginal fistula caused by radiation therapy, yet total pelvic exenteration frequently causes intraoperative complications and postoperative complications. These complications are responsible for the dysfunction of lower extremities, impaired quality of life, and even the high long-term morbidity rate, thus multidisciplinary cooperation and early intervention for prevention of complications are necessary. Physical therapy was found to reduce the postoperative complications and promote rehabilitation, yet the effect on how physiotherapy prevents and treats complications after total pelvic exenteration and pelvic lymphadenectomy remains unclear...
April 13, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38608335/comparative-analysis-of-whole-cell-derived-vesicular-delivery-systems-for-photodynamic-therapy-of-extrahepatic-cholangiocarcinoma
#12
JOURNAL ARTICLE
Mingjuan Li, Esmeralda D C Bosman, Olivia M Smith, Nicole Lintern, Daniel J de Klerk, Hong Sun, Shuqun Cheng, Weiwei Pan, Gert Storm, Yazan S Khaled, Michal Heger
This first-in-its-class proof-of-concept study explored the use of bionanovesicles for the delivery of photosensitizer into cultured cholangiocarcinoma cells and subsequent treatment by photodynamic therapy (PDT). Two types of bionanovesicles were prepared: cellular vesicles (CVs) were fabricated by sonication-mediated nanosizing of cholangiocarcinoma (TFK-1) cells, whereas cell membrane vesicles (CMVs) were produced by TFK-1 cell and organelle membrane isolation and subsequent nanovesicularization by sonication...
April 2, 2024: Journal of Photochemistry and Photobiology. B, Biology
https://read.qxmd.com/read/38603561/comparative-study-of-sonodynamic-and-photoactivated-cancer-therapies-with-re-i-tricarbonyl-complexes-comprising-phenanthroline-ligands
#13
JOURNAL ARTICLE
Rajesh Kushwaha, Virendra Singh, Silda Peters, Ashish Kumar Yadav, Tumpa Sadhukhan, Biplob Koch, Samya Banerjee
Herein, we have compared the effectivity of light-based photoactivated cancer therapy and ultrasound-based sonodynamic therapy with Re(I)-tricarbonyl complexes ( Re1 - Re3 ) against cancer cells. The observed photophysical and TD-DFT calculations indicated the potential of Re1 - Re3 to act as good anticancer agents under visible light/ultrasound exposure. Re1 did not display any dark- or light- or ultrasound-triggered anticancer activity. However, Re2 and Re3 displayed concentration-dependent anticancer activity upon light and ultrasound exposure...
April 11, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38603515/unveiling-the-spatiotemporal-and-dose-responses-within-a-single-live-cancer-cell-to-photoswitchable-upconversion-nanoparticle-therapeutics-using-hybrid-hyperspectral-stimulated-raman-scattering-and-transient-absorption-microscopy
#14
JOURNAL ARTICLE
Le Xin, Zichao Luo, Xiaogang Liu, Zhiwei Huang
Photodynamic therapy (PDT) provides an alternative approach to targeted cancer treatment, but the therapeutic mechanism of advanced nanodrugs applied to live cells and tissue is still not well understood. Herein, we employ the hybrid hyperspectral stimulated Raman scattering (SRS) and transient absorption (TA) microscopy developed for real-time in vivo visualization of the dynamic interplay between the unique photoswichable lanthanide-doped upconversion nanoparticle-conjugated rose bengal and triphenylphosphonium (LD-UCNP@CS-Rb-TPP) probe synthesized and live cancer cells...
April 11, 2024: Analytical Chemistry
https://read.qxmd.com/read/38596305/crispr-editing-to-mimic-porphyria-combined-with-light-a-new-preclinical-approach-for-prostate-cancer
#15
JOURNAL ARTICLE
Julian Boutin, Coralie Genevois, Franck Couillaud, Isabelle Lamrissi-Garcia, Veronique Guyonnet-Duperat, Alice Bibeyran, Magalie Lalanne, Samuel Amintas, Isabelle Moranvillier, Emmanuel Richard, Jean-Marc Blouin, Sandrine Dabernat, François Moreau-Gaudry, Aurélie Bedel
Thanks to its very high genome-editing efficiency, CRISPR-Cas9 technology could be a promising anticancer weapon. Clinical trials using CRISPR-Cas9 nuclease to ex vivo edit and alter immune cells are ongoing. However, to date, this strategy still has not been applied in clinical practice to directly target cancer cells. Targeting a canonical metabolic pathway essential to good functioning of cells without potential escape would represent an attractive strategy. We propose to mimic a genetic metabolic disorder in cancer cells to weaken cancer cells, independent of their genomic abnormalities...
March 21, 2024: Mol Ther Oncol
https://read.qxmd.com/read/38594624/composite-microparticles-from-microfluidics-for-chemo-photothermal-therapy-of-hepatocellular-carcinoma
#16
JOURNAL ARTICLE
Tianyuan Xu, Li Wang, Lu Fan, Haozhen Ren, Qingfei Zhang, Jinglin Wang
Hydrogel microcarrier-based drug delivery systems are of great value in the combination therapy of tumors. Current research directions concentrate on the development of more economic, convenient, and effective combined therapeutic platforms. Herein, we developed novel adhesive composite microparticles (MPPMD ) with combined chemo- and photothermal therapy ability via microfluidic electrospray technology for local hepatocellular carcinoma treatment. These composite microparticles consisted of doxorubicin (DOX)-loaded and polydopamine-wrapped mesoporous silicon and alginate...
April 9, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38590307/predictors-of-disease-recurrence-after-radical-resection-and-adjuvant-chemotherapy-in-patients-with-stage-iib-iiia-squamous-cell-lung-cancer-a-retrospective-analysis
#17
JOURNAL ARTICLE
Marina A Senchukova, Evgeniy A Kalinin, Nadezhda N Volchenko
BACKGROUND: Lung cancer (LC) is a global medical, social and economic problem and is one of the most common cancers and the leading cause of mortality from malignant neoplasms. LC is characterized by an aggressive course, and in the presence of disease recurrence risk factors, patients, even at an early stage, may be indicated for adjuvant therapy to improve survival. However, combined treatment does not always guarantee a favorable prognosis. In this regard, establishing predictors of LC recurrence is highly important both for determining the optimal treatment plan for the patients and for evaluating its effectiveness...
March 20, 2024: World Journal of Experimental Medicine
https://read.qxmd.com/read/38582750/tumor-activated-in-situ-synthesis-of-single-atom-catalysts-for-o-2-independent-photodynamic-therapy-based-on-water-splitting
#18
JOURNAL ARTICLE
Yiyan Yin, Xiyang Ge, Jin Ouyang, Na Na
Single-atom catalysts (SACs) have attracted interest in photodynamic therapy (PDT), while they are normally limited by the side effects on normal tissues and the interference from the Tumor Microenvironment (TME). Here we show a TME-activated in situ synthesis of SACs for efficient tumor-specific water-based PDT. Upon reduction by upregulated GSH in TME, C3 N4 -Mn SACs are obtained in TME with Mn atomically coordinated into the cavity of C3 N4 nanosheets. This in situ synthesis overcomes toxicity from random distribution and catalyst release in healthy tissues...
April 6, 2024: Nature Communications
https://read.qxmd.com/read/38568336/development-of-chitosan-folate-modified-plga-nanoparticles-for-targeted-delivery-of-diosgenin-as-an-anticancer-agent
#19
JOURNAL ARTICLE
Fatemeh Teymouri, Ehsan Karimi
Diosgenin as a potential phytoconstituent and steroidal saponin manifested significant anticancer agents against various cancers. To enhance its solubility and bioavailability in cancer treatment, we loaded diosgenin (PubChem CID: 99474) in poly(lactic-co-glycolide) (PLGA) nanoparticle coated with folic acid-chitosan (Da-PFC-NPs). The diosgenin nano-formulation was characterized and its antioxidant and anticancer properties were surveyed respectively. The obtained results illustrated that the Da-PFC-NPs were spherical and stable with a size of 218 nm and a polydispersity index of 0...
April 3, 2024: Discover. Oncology
https://read.qxmd.com/read/38566121/a-paradigm-shift-in-cancer-research-based-on-integrative-multi-omics-approaches-glutaminase-serves-as-a-pioneering-cuproptosis-related-gene-in-pan-cancer
#20
JOURNAL ARTICLE
Hai-Hong Shi, Joseph Mugaanyi, Changjiang Lu, Yang Li, Jing Huang, Lei Dai
BACKGROUND: Cuproptosis is a newly identified form of unprogrammed cell death. As a pivotal metabolic regulator, glutaminase (GLS) has recently been discovered to be linked to cuproptosis. Despite this discovery, the oncogenic functions and mechanisms of GLS in various cancers are still not fully understood. METHODS: In this study, a comprehensive omics analysis was performed to investigate the differential expression levels, diagnostic and prognostic potential, correlation with tumor immune infiltration, genetic alterations, and drug sensitivity of GLS across multiple malignancies...
April 2, 2024: BMC Women's Health
keyword
keyword
82861
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.